Lyka Labs Stock (NSE:LYKALABS)


INR 182.30
Today's Range
INR175.00 - INR182.30
52-Week Range
INR41.00 - INR267.00
Market Cap

About Lyka Labs (NSE:LYKALABS)

(NSE:LYKALABS) Lyka Labs Limited engages in manufacturing pharmaceutical formulations and active pharmaceutical ingredients various therapeutic segments in India. It manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, muscle relaxant, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. The company also provides contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, BA/BE clinical study data, etc. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia, as well as deals in pharmaceutical products. Lyka Labs Limited offers its products in various formulations, including injections, creams, ointments, foams, gels, and lotions. Further, the company exports its products to Bangladesh, Combodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.
Show more

LYKALABS Stock Price

Statistics Highlights (NSE:LYKALABS)

Shares Outstanding 28.69M Beta 1.32
Public Float 15.59M P/E Ratio 8.06
% Short of Float - Dividend (Yield) -
Held by Insiders 54.25% Ex-Dividend Date
Held by Institutions - IPO Date -

LYKALABS Financial Summary

Mar 21 Mar 20 Mar 19
Revenue INR671.07M INR554.08M INR642.38M
EBITDA INR183.70M INR-101.35M INR-17.59M
Net Income INR-115.55M INR-605.41M INR-55.50M
Total Assets INR1.90B INR2.00B INR2.17B
Total Cash INR2.36M INR1.79M INR-2.83M
Total Debt INR1.63B INR1.44B INR976.41M
Dec 21 Sep 21 Jun 21
Revenue INR355.74M INR738.89M INR494.37M
EBITDA INR136.03M INR431.80M INR304.37M
Net Income INR60.86M INR284.33M INR195.51M
Total Assets INR INR1.98B INR
Total Cash INR INR111.99M INR
Total Debt INR INR1.25B INR

LYKALABS Stock Price History

Lyka Labs Annual Stock Price History

Year Open Close Change
2021 INR216.00 INR182.30 -15.60%
2021 INR32.55 INR216.00 563.59%
2020 INR19.25 INR32.55 69.09%

Lyka Labs Daily Stock Price History

Date Open High Low Close Change Volume
Jun 17, 2022 INR116.00 INR119.00 INR114.00 INR116.65 -6.61% 69.55K
Jun 14, 2022 INR125.85 INR128.30 INR124.10 INR124.90 -0.24% 182.24K
Jun 9, 2022 INR120.60 INR127.45 INR120.10 INR125.20 7.38% 111.70K


What is today's stock price of Lyka Labs (NSE:LYKALABS)?

  • The current stock price of Lyka Labs (NSE:LYKALABS) is INR182.30.
  • Today LYKALABS stock price opened at INR175.00 after previous close of INR173.65.
  • During the day, Lyka Labs stock quote has varied from a low of INR175.00 to a high of INR182.30.

What is Lyka Labs's 52-week change?

  • LYKALABS 52-week high stock quote is INR267.00, which is 46.50% above the current share price.
  • The Lyka Labs (NSE:LYKALABS) 52-week low stock price is INR41.00, which is 77.50% below the current share price.
  • Lyka Labs share price volatility (52-week beta) is 1.32.


How Much is Lyka labs Worth?

Lyka labs's worth today based on market capitalisation is INR4.42B

How much dividend does Lyka labs Pay?

The current annualized dividend payout for LYKALABS stock is INR0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Lyka labs's "Dividend" Section

What is Lyka labs’s Price to Earning (PE) ratio?

Lyka labs has a Price to Earning (P/E) ratio of 8.06. LYKALABS stock also has a Price to Sales (P/S) ratio of 2.67.

What is the Lyka labs's ticker?

Lyka labs trades on the NSE stock market in India under the ticker symbol "LYKALABS". Lyka labs’s stock symbol can also be displayed as "NSE:LYKALABS".

Who are the owners of Lyka labs?

Lyka labs (NSE:LYKALABS) is owned by 0.00% institutional shareholders and by 54.25% insiders. The rest is owned by the public.
Explore More Details on Lyka labs's “Ownership” Section

Who are the key executives of Lyka labs (LYKALABS)?

Lyka labs's key executive team includes the following managers:

  • Mr. Kunal Narendra Gandhi, Chairman, MD & CEO (1987)
  • Mr. Yogesh Babulal Shah, CFO & Exec. Director (1960)
  • Mr. Piyush Girishchandra Hindia, Company Sec. & Compliance Officer (NA)
  • Mr. B. S. Arun Rao, CEO of Lyka BDR International Ltd and Whole-Time Director of Lyka BDR International Ltd (NA)

What is Lyka labs’s Sector & Industry Classification?

Lyka labs (NSE:LYKALABS) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Lyka labs?

Currently the number of employees working for Lyka labs is 99.

Where are Lyka labs's Headquarters?

Lyka labs (NSE:LYKALABS) is headquartered in India.

What are Lyka labs's Address and Phone Number?

Lyka labs’s mailing address is Spencer Building, Mumbai, India, 400036.
The company’s phone number is 91 22 6611 2200.

What is the official website for Lyka labs?

Lyka labs’s official website is